These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27082535)

  • 1. Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
    Kolwijck E; van der Hoeven H; de Sévaux RG; ten Oever J; Rijstenberg LL; van der Lee HA; Zoll J; Melchers WJ; Verweij PE
    Am J Respir Crit Care Med; 2016 Apr; 193(8):927-9. PubMed ID: 27082535
    [No Abstract]   [Full Text] [Related]  

  • 2. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
    Negri CE; Gonçalves SS; Sousa ACP; Bergamasco MD; Martino MDV; Queiroz-Telles F; Aquino VR; Castro PTO; Hagen F; Meis JF; Colombo AL
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893772
    [No Abstract]   [Full Text] [Related]  

  • 3. Infectious Disease. How to bolster the antifungal pipeline.
    Denning DW; Bromley MJ
    Science; 2015 Mar; 347(6229):1414-6. PubMed ID: 25814567
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of aspergillosis in the Netherlands: a national survey.
    Lestrade PP; Meis JF; Arends JP; van der Beek MT; de Brauwer E; van Dijk K; de Greeff SC; Haas PJ; Hodiamont CJ; Kuijper EJ; Leenstra T; Muller AE; Oude Lashof AM; Rijnders BJ; Roelofsen E; Rozemeijer W; Tersmette M; Terveer EM; Verduin CM; Wolfhagen MJ; Melchers WJ; Verweij PE
    Mycoses; 2016 Feb; 59(2):101-7. PubMed ID: 26648179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
    Agbetile J; Bourne M; Fairs A; Hargadon B; Desai D; Broad C; Morley J; Bradding P; Brightling CE; Green RH; Haldar P; Pashley CH; Pavord ID; Wardlaw AJ
    J Allergy Clin Immunol; 2014 Jul; 134(1):33-9. PubMed ID: 24290286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States.
    Walker TA; Lockhart SR; Beekmann SE; Polgreen PM; Santibanez S; Mody RK; Beer KD; Chiller TM; Jackson BR
    Emerg Infect Dis; 2018 Jan; 24(1):111-3. PubMed ID: 29261092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
    Prajna NV; Prajna L; O'Brien KS; Sun CQ; Acharya N; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2015 Oct; 133(10):1210-1. PubMed ID: 26110254
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Chowdhary A; Sharma C; Hagen F; Meis JF
    Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
    Lestrade PP; Bentvelsen RG; Schauwvlieghe AFAD; Schalekamp S; van der Velden WJFM; Kuiper EJ; van Paassen J; van der Hoven B; van der Lee HA; Melchers WJG; de Haan AF; van der Hoeven HL; Rijnders BJA; van der Beek MT; Verweij PE
    Clin Infect Dis; 2019 Apr; 68(9):1463-1471. PubMed ID: 30307492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure.
    Abidi MZ; D'Souza A; Kuppalli K; Ledeboer N; Hari P
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):46-8. PubMed ID: 25986028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
    Forastiero A; Bernal-Martínez L; Mellado E; Cendejas E; Gomez-Lopez A
    Int J Antimicrob Agents; 2015 Nov; 46(5):511-7. PubMed ID: 26358971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
    Seyedmousavi S; Mouton JW; Melchers WJ; Brüggemann RJ; Verweij PE
    Drug Resist Updat; 2014 Jul; 17(3):37-50. PubMed ID: 25066814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
    J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive aspergillosis in a paediatric allogeneic stem cell transplantation recipient owing to a susceptible Aspergillus fumigatus: Treatment failure with high doses of voriconazole and influence of CYP2C19 polymorphisms.
    Cendejas-Bueno E; Borobia AM; Gomez-Lopez A; Escosa-García L; Río-García M; Plaza D; García-Rodriguez J; Carcas-Sansuán A
    Int J Antimicrob Agents; 2016 May; 47(5):410-1. PubMed ID: 27056297
    [No Abstract]   [Full Text] [Related]  

  • 18. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
    Verweij PE; Ananda-Rajah M; Andes D; Arendrup MC; Brüggemann RJ; Chowdhary A; Cornely OA; Denning DW; Groll AH; Izumikawa K; Kullberg BJ; Lagrou K; Maertens J; Meis JF; Newton P; Page I; Seyedmousavi S; Sheppard DC; Viscoli C; Warris A; Donnelly JP
    Drug Resist Updat; 2015; 21-22():30-40. PubMed ID: 26282594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
    J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed infection with itraconazole-susceptible and-resistant strains of Aspergillus fumigatus: Diagnostic and therapeutic implications.
    Ahmad S; Khan Z
    J Infect Public Health; 2020 Apr; 13(4):664-666. PubMed ID: 32171723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.